Shares of Sanofi (SNY) Sees Large Inflow of Net Money Flow

Sanofi (SNY) : Mondays money flow indicated an uptick to downtick ratio was at 3.85. The total value of inflow transactions on upticks was $24.87 million, whereas, the total value of outflow trades on downticks was $6.46 million. The total money flow was $18.42 million, which shows a mild bullish bias. The total money flow into the stock in block trades was $18.41 million. The total value of the trades done on upticks was $18.41 million. Sanofi (SNY) was trading with a -0.24% change over previous days close. It fell $0.1 during the day and reached $41.58. The stock was 1.79% compared to the previous weeks close.


Sanofi has dropped 0.89% during the last 3-month period . Year-to-Date the stock performance stands at 1.59%. Shares of Sanofi rose by 0.39% in the last five trading days and 8.28% for the last 4 weeks.

Sanofi (NYSE:SNY): On Mondays trading session , Opening price of the stock was $41.44 with an intraday high of $41.8027. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $41.33. However, the stock managed to close at $41.58, a loss of 0.24% for the day. On the previous day, the stock had closed at $41.68. The total traded volume of the day was 1,457,777 shares.

Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products. The emerging markets platform includes products from all three of the Companys principal activities. Under the Companys Pharmaceuticals business, products are grouped into the key fields of diabetes solutions, rare diseases, multiple sclerosis, oncology, thrombosis and cardiovascular disease prevention, nephrology and bio-surgery. The Human Vaccines activity is operated through Sanofi Pasteur. The Animal Health activity is carried out through Merial.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.